Takeda Receives European Commission Marketing Authorisation for Entyvio® (vedolizumab) for the Treatment of Ulcerative C

VALUATION - A stock's value is a function of its forecasted earnings per share and forecasted earnings growth, as well as profitability, interest and inflation rates. Valuation use these metrics to determine at what price a stock is undervalued or overvalued, so that you can make investment decisions accordingly.

INSIDER - Significant stock sales or purchases by company "insiders" (officers or directors) can be a predictor of future price movements, up or down. The Insider strategy tracks these actions and correlates them with historical data to give you an investment edge.

DISCLAIMER:

WEALTHMAKERS is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. WEALTHMAKERS has received $1,117 per month from the Company for data provided in this report. Past performance is not indicative of future results. Please visit our web site, www.wealthmakers.com [http://www.wealthmakers.com ] , for complete risks and disclosures.

Contact:

WEALTHMAKERS 1-516-858-1113 tom@wealthmakers.com http://www.wealthmakers.com

About Discovery Minerals LTD.:

Discovery Minerals Ltd., is an acquisition and development company that targets natural resource properties through its subsidiaries. These properties fall within two primary channels, precious metals/mining and industrial hemp. Discovery subsidiaries engage in activities that include the cultivation, product development, and distribution of industrial hemp; Gold, silver and precious metals. In addition, the Company is pursuing clean tech and alternative energy investments to be integrated into these business channels.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors [http://www.otcmarkets.com/stock/DSCR/news/Discovery-Minerals... ]

are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to

obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Person:

Russell Smith

1--310-961-4654

At: info@discoveryholdingscorp.com

Source: Discovery Minerals LTD.:

CONTACT: Contact: Danny Stepto, Takeda Pharmaceuticals International GmbH,TEL: +41-44-555-1504, Danny.Stepto@takeda.com. Takeda PharmaceuticalCompany, Corporate Communications Dept. (PR/IR), TEL: +81-3-3278-2037.